Stay updated on Nivolumab in Untreated Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab in Untreated Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedRecruitment status note and new help sections were added, and the Intervention/Treatment header formatting was updated; the page revision was updated to v3.6.0 and the previous revision v3.5.5 was removed.SummaryDifference0.3%

- Check11 days agoChange DetectedThe page shows a revision update from v3.5.4 to v3.5.5, indicating the study record has been refreshed.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4. This represents a minor update to the revision history, with no evident changes to the page content based on the provided data.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page’s application/software revision indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site update rather than a change to the study record.SummaryDifference0.0%

- Check61 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check68 days agoChange DetectedNew update entries dated 2026-04-06, 2026-03-17, and 2026-03 were added, while entries from 2025-03-05, 2025-02-26, and 2025-02 were removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab in Untreated Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.